Valneva raises €61 million in accelerated bookbuilding offering

Client(s) Valneva SE

Jones Day advised Valneva SE, a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs, in connection with its capital €61 million private placement through an accelerated bookbuilding process.